نتائج البحث

FDA Approves Novel Cyclosporine for Dye Eye Disease.

Subjects: Drug approval; Drug efficacy; Dry eye syndromes

• Source: Formulary Watch. 6/8/2023, p1-1. 1p. 1 Color Photograph.

تفاصيل العنوان

Quantum Leap Stops Cyclosporine Arm of I-SPY COVID Trial.

Subjects: Clinical trial laws; Biomarkers; COVID-19

• Source: Formulary Watch. 8/12/2022, p2-2. 1p.

تفاصيل العنوان

Harrow Launches Vevye for Dry Eye Disease.

Subjects: Drug approval; Dry eye syndromes; Bioavailability

• Source: Formulary Watch. 1/11/2024, p1-1. 1p.

تفاصيل العنوان

Novartis Recalls Two Additional Lots of Sandimune.

Subjects: Drug efficacy; Clinical drug trials; Graft rejection

• Source: Formulary Watch. 11/27/2023, p1-1. 1p.

تفاصيل العنوان

FDA Approves Liquid Mycophenolate to Prevent Organ Rejections.

Subjects: Kidney transplantation; Combination drug therapy; Adrenocortical hormones

• Source: Formulary Watch. 5/7/2024, p1-1. 1p.

تفاصيل العنوان

FDA Accepts NDA for Novaliq's New Dry Eye Therapy.

Subjects: Drug approval; Meibomian glands; Dry eye syndromes

• Source: Formulary Watch. 10/24/2022, p1-1. 1p.

تفاصيل العنوان

Novaliq Submits NDA for Dry Eye Treatment.

Subjects: Drug approval; Drug efficacy; Meibomian glands

• Source: Formulary Watch. 8/10/2022, p3-3. 1p.

تفاصيل العنوان

Crystal Formation in Bottles Leads to Recall of Sandimmune.

Subjects: Graft rejection; Patients; Cyclosporine

• Source: Formulary Watch. 9/11/2023, p1-1. 1p.

تفاصيل العنوان

FDA Approves First Generic to Restasis Eye Drops.

• Authors : Blank, Christine

Subjects: Drug approval; Dry eye syndromes; United States. Food & Drug Administration

• Source: Formulary Watch. 2/4/2022, p1-1. 1p.

تفاصيل العنوان